Tenderfy

EMBED 3.0 - Improvement of Formulations

Auftraggeber
Cardiff University
Veröffentlicht
2026-10-19
Frist
Nicht angegeben
Quellen
UK_FTS
Wert
Nicht angegeben

Beschreibung

Die Beschreibung ist in der Sprache der Quelle.

The B&M Gates Foundation (funder) have reviewed the work with the EMBED research team, undertaken with the manufacturer ProMed, and have decided that to push the EMBED 3.0 project into its next stage (EMBED 4.0 – Human Trials), they’ll need to demonstrate their ability to vary the additional batches offer a more robust mechanism for the medications to enter patients. The additional work has been again funded by the foundation for the purpose of increasing the viability of the delivery method (technology developed as part of EMBED) - Previous direct award for the initial development via Regulation 41 - Schedule 5, para 2.

Mitgliedschaft

Vorschauen sind kostenlos. Links zu offiziellen Bekanntmachungen und Dokumenten, Baugenehmigungen und persönlicher MCP-Zugang erfordern eine aktive kostenpflichtige Mitgliedschaft.

Lesen